Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.47 (
cysteine synthase
)
625
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In addition to its classic glycolytic role,
glyceraldehyde-3-phosphate dehydrogenase
(
GAPDH
) has been implicated in many activities unrelated to glycolysis, such as membrane fusion, binding to host proteins and signal transduction.
GAPDH
can be the target of several modifications that allow incorporation to membranes and possible regulation of its activity; among these modifications is mono-ADP-ribosylation. This post-translational modification is important for the regulation of many cellular processes and is the mechanism of action of several bacterial toxins. In a previous study, we observed the extracellular ADP-ribosylation of a 37-kDa ameba protein. We report here that
GAPDH
and
cysteine synthase
A are the main ADP-ribosylated proteins in Entamoeba histolytica extracellular medium,
GAPDH
is secreted from ameba at 37 degrees C in a time-dependent manner, and its enzymatic activity is not inhibited by ADP-ribosylation. Extracellular
GAPDH
from ameba may play an important role in the survival of this human pathogen or in interaction with host molecules, as occurs in other organisms.
...
PMID:Entamoeba histolytica: ADP-ribosylation of secreted glyceraldehyde-3-phosphate dehydrogenase. 1758 98